These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 28358102

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Systems biology of Ewing sarcoma: a network model of EWS-FLI1 effect on proliferation and apoptosis.
    Stoll G, Surdez D, Tirode F, Laud K, Barillot E, Zinovyev A, Delattre O.
    Nucleic Acids Res; 2013 Oct; 41(19):8853-71. PubMed ID: 23935076
    [Abstract] [Full Text] [Related]

  • 6. A polypeptide from the junction region sequence of EWS-FLI1 inhibits Ewing's sarcoma cells, interacts with the EWS-FLI1 and partner proteins.
    Thangaretnam KP, Gopisetty G, Ramanathan P, Rajkumar T.
    Sci Rep; 2017 Aug 03; 7(1):7172. PubMed ID: 28775288
    [Abstract] [Full Text] [Related]

  • 7. Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma.
    Hensel T, Giorgi C, Schmidt O, Calzada-Wack J, Neff F, Buch T, Niggli FK, Schäfer BW, Burdach S, Richter GH.
    Oncotarget; 2016 Jan 12; 7(2):1451-63. PubMed ID: 26623725
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetic modeling optimizes inhibition of the 'undruggable' EWS-FLI1 transcription factor in Ewing Sarcoma.
    Hong SH, Youbi SE, Hong SP, Kallakury B, Monroe P, Erkizan HV, Barber-Rotenberg JS, Houghton P, Üren A, Toretsky JA.
    Oncotarget; 2014 Jan 30; 5(2):338-50. PubMed ID: 24481407
    [Abstract] [Full Text] [Related]

  • 9. Functional Genomic Screening Reveals Splicing of the EWS-FLI1 Fusion Transcript as a Vulnerability in Ewing Sarcoma.
    Grohar PJ, Kim S, Rangel Rivera GO, Sen N, Haddock S, Harlow ML, Maloney NK, Zhu J, O'Neill M, Jones TL, Huppi K, Grandin M, Gehlhaus K, Klumpp-Thomas CA, Buehler E, Helman LJ, Martin SE, Caplen NJ.
    Cell Rep; 2016 Jan 26; 14(3):598-610. PubMed ID: 26776507
    [Abstract] [Full Text] [Related]

  • 10. Therapeutic opportunities in Ewing sarcoma: EWS-FLI inhibition via LSD1 targeting.
    Theisen ER, Pishas KI, Saund RS, Lessnick SL.
    Oncotarget; 2016 Apr 05; 7(14):17616-30. PubMed ID: 26848860
    [Abstract] [Full Text] [Related]

  • 11. Synthetic siRNA targeting the breakpoint of EWS/Fli-1 inhibits growth of Ewing sarcoma xenografts in a mouse model.
    Takigami I, Ohno T, Kitade Y, Hara A, Nagano A, Kawai G, Saitou M, Matsuhashi A, Yamada K, Shimizu K.
    Int J Cancer; 2011 Jan 01; 128(1):216-26. PubMed ID: 20648560
    [Abstract] [Full Text] [Related]

  • 12. RETRACTED: Combining PARP-1 inhibition and radiation in Ewing sarcoma results in lethal DNA damage.
    Lee HJ, Yoon C, Schmidt B, Park DJ, Zhang AY, Erkizan HV, Toretsky JA, Kirsch DG, Yoon SS.
    Mol Cancer Ther; 2013 Nov 01; 12(11):2591-600. PubMed ID: 23966622
    [Abstract] [Full Text] [Related]

  • 13. TRIM8 modulates the EWS/FLI oncoprotein to promote survival in Ewing sarcoma.
    Seong BKA, Dharia NV, Lin S, Donovan KA, Chong S, Robichaud A, Conway A, Hamze A, Ross L, Alexe G, Adane B, Nabet B, Ferguson FM, Stolte B, Wang EJ, Sun J, Darzacq X, Piccioni F, Gray NS, Fischer ES, Stegmaier K.
    Cancer Cell; 2021 Sep 13; 39(9):1262-1278.e7. PubMed ID: 34329586
    [Abstract] [Full Text] [Related]

  • 14. Preclinical Justification of pbi-shRNA EWS/FLI1 Lipoplex (LPX) Treatment for Ewing's Sarcoma.
    Rao DD, Jay C, Wang Z, Luo X, Kumar P, Eysenbach H, Ghisoli M, Senzer N, Nemunaitis J.
    Mol Ther; 2016 Aug 13; 24(8):1412-22. PubMed ID: 27166877
    [Abstract] [Full Text] [Related]

  • 15. Plasma hydrogenated cationic detonation nanodiamonds efficiently deliver to human cells in culture functional siRNA targeting the Ewing sarcoma junction oncogene.
    Bertrand JR, Pioche-Durieu C, Ayala J, Petit T, Girard HA, Malvy CP, Le Cam E, Treussart F, Arnault JC.
    Biomaterials; 2015 Mar 13; 45():93-8. PubMed ID: 25662499
    [Abstract] [Full Text] [Related]

  • 16. Primary Hepatic Ewing Sarcoma With EWS-FLI1 RNA Transcript in a Child.
    Pochon C, Martelli H, Mussini C, Pariente D, Heymann MF, Corradini N.
    J Pediatr Hematol Oncol; 2015 Jul 13; 37(5):411-3. PubMed ID: 25411865
    [No Abstract] [Full Text] [Related]

  • 17. A Druggable Rheostat for Ewing Sarcoma?
    Weiss KR, Bailey KM.
    Clin Cancer Res; 2022 Oct 14; 28(20):4360-4362. PubMed ID: 35921177
    [Abstract] [Full Text] [Related]

  • 18. Combined analysis of gene expression and genome binding profiles identified potential therapeutic targets of ciclopirox in Ewing sarcoma.
    Yuan B, Ji W, Xia H, Li J.
    Mol Med Rep; 2018 Mar 14; 17(3):4291-4298. PubMed ID: 29328472
    [Abstract] [Full Text] [Related]

  • 19. EWS/FLI mediated reprogramming of 3D chromatin promotes an altered transcriptional state in Ewing sarcoma.
    Showpnil IA, Selich-Anderson J, Taslim C, Boone MA, Crow JC, Theisen ER, Lessnick SL.
    Nucleic Acids Res; 2022 Sep 23; 50(17):9814-9837. PubMed ID: 36124657
    [Abstract] [Full Text] [Related]

  • 20. PI3K/AKT signaling modulates transcriptional expression of EWS/FLI1 through specificity protein 1.
    Giorgi C, Boro A, Rechfeld F, Lopez-Garcia LA, Gierisch ME, Schäfer BW, Niggli FK.
    Oncotarget; 2015 Oct 06; 6(30):28895-910. PubMed ID: 26336820
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.